Results 91 to 100 of about 40,229 (203)

Microbiological Quality and Analysis of Escherichia coli Resistance to Antibiotics in Beaches: Evaluating Anthropic Influence in Surface Waters in Brazil

open access: yesWater Environment Research, Volume 98, Issue 11, November 2026.
Anthropic activities and untreated wastewater promote the dissemination of antibiotic‐resistant E. coli (83.3% of isolates) in coastal waters, increasing environmental contamination and public health risks. ABSTRACT Antimicrobial resistance is a problem for public health.
Monica M. Elias   +8 more
wiley   +1 more source

In Vitro Evaluation of the Antimicrobial Activity of Origanum vulgare Essential Oil Against ESBL-Producing Strains of Escherichia coli and Klebsiella pneumoniae

open access: yesCurrent Issues in Molecular Biology
One of the greatest threats to global public health is antimicrobial resistance (AMR), due to the increasing number of infections caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. Escherichia coli and Klebsiella pneumoniae ESBL-
Andrea González Carrión   +3 more
doaj   +1 more source

Antimicrobial Resistance in Periodontal Disease: Rethinking Adjunctive Therapy in the Metagenomics Era, the Pressing Need for Precision Treatment and Periodontal Resistome Mapping

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Systemic antibiotics are effective when used as adjunctive therapy in the treatment of periodontitis; however, their use must be balanced against antimicrobial resistance, which is a major threat to global public health. This review provides an expert synthesis of the literature and a field‐level overview of antimicrobial resistance in ...
Meera Alghafri   +3 more
wiley   +1 more source

CEFEPIME/ENMETAZOBACTAM: Physicochemical Stability of a Novel β-Lactam/β-Lactamase Inhibitor Combination in Syringes and Elastomeric Devices

open access: yesAntibiotics
Background: Cefepime/enmetazobactam (FEP/META) is a novel fixed-dose β-lactam/β-lactamase inhibitor combination. The objective was to study the physicochemical stability of the approved daily dose in polypropylene syringes and elastomeric devices over a ...
Akim Chayem   +9 more
doaj   +1 more source

Cefepime-induced encephalopathy [PDF]

open access: yes, 2018
61-year-old man has been unable to leave his bed since being diagnosed with cerebral palsy at the age of 2 years. He is fed via a gastrostoma and has previously contracted aspiration pneumonitis three times. He has had no history of seizures or myoclonic
Matsumoto, Masanori, Kenzaka, Tsuneaki
core   +1 more source

Cefepime Alleviates Comorbid Pain and Depression Induced by Lipopolysaccharide in Female Mice

open access: yesBrain Sciences
Background/Objectives: Evidence indicates that aberrant glutamate transporter function and expression are linked to the pathophysiology of comorbid major depressive disorder (MDD) and pain.
Amna Khan   +2 more
doaj   +1 more source

Encefalopatia induzida por cefepime: achados clínicos e eletroencefalográficos em sete pacientes Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients

open access: yesArquivos de Neuro-Psiquiatria, 2005
Cefepime, uma cefalosporina de quarta geração, com amplo espectro de ação, é um antibiótico largamente utilizado no tratamento de infecções graves em ambientes hospitalares. O registro de segurança deste fármaco é considerado favorável.
José Augusto Bragatti   +3 more
doaj   +1 more source

Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance

open access: yes, 2020
Background: We investigated the treatment outcomes before and after the addition of amikacin to cefepime monotherapy as an initial empirical antibiotic treatment in pediatric cancer patients with febrile neutropenia.
강지만
core   +1 more source

Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro

open access: yes, 2000
Cefepime, a broad-spectrum, fourth-generation cephalosporin, showed excellent CSF penetration with levels ranging between 10 and 16 mg/L after two intravenous injections (100 mg/kg).
Cottagnoud, M   +11 more
core   +1 more source

Cefepime-induced neurotoxicity: a systematic review

open access: yes, 2017
Background Cefepime is a widely used antibiotic with neurotoxicity attributed to its ability to cross the blood–brain barrier and exhibit concentration-dependent ϒ-aminobutyric acid (GABA) antagonism.
Gagnon, David J   +13 more
core   +2 more sources

Home - About - Disclaimer - Privacy